State of Wisconsin Investment Board’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History

State of Wisconsin Investment Board’s Portfolio LOGC Stock Details LOGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-22,800	Closed	-$166K	–	2192
2021 Q1	$166K	Hold	22,800	–	–	﹤0.01%	2008
2020 Q4	$174K	Buy	+22,800	New	+$153K	﹤0.01%	1958
2020 Q1	–	Sell	-11,400	Closed	-$82K	–	1752
2019 Q4	$82K	Hold	11,400	–	–	﹤0.01%	1610
2019 Q3	$123K	Hold	11,400	–	–	﹤0.01%	1525
2019 Q2	$148K	Buy	+11,400	New	+$151K	﹤0.01%	1505

Other funds holding LOGC

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

State of Wisconsin Investment Board's LOGC Position: Q2 2021 in Review

State of Wisconsin Investment Board sold out of LogicBio Therapeutics, Inc. Common Stock (LOGC) in Q2 2021, closing a stake of 22,800 shares — an estimated $166K sold.

State of Wisconsin Investment Board first reported a position in LOGC in Q2 2019 and held it in 5 quarters. The position peaked at $174K in Q4 2020. 63 funds tracked by Wall St. Rank hold LOGC as of Q2 2021.

State of Wisconsin Investment Board reported no remaining LogicBio Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
State of Wisconsin Investment Board sold 22,800 LogicBio Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $166K.
State of Wisconsin Investment Board first reported a position in LogicBio Therapeutics, Inc. Common Stock in Q2 2019 and held it in 5 quarters.
State of Wisconsin Investment Board's LogicBio Therapeutics, Inc. Common Stock position peaked at $174K in Q4 2020.
63 funds tracked by Wall St. Rank held LogicBio Therapeutics, Inc. Common Stock as of Q2 2021.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2021, filed 12 Aug 2021.